[Complications of immunosuppressive therapy using cytostatics in autoaggression diseases with special reference to cholestatic hepatosis].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000188:drug therapy*; D001379:Azathioprine / Q000009:adverse effects* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury; D002779:Cholestasis / Q000139:chemically induced*; D002908:Chronic Disease; D003882:Dermatomyositis / Q000188:drug therapy; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D015122:Mercaptopurine / Q000009:adverse effects* / Q000627:therapeutic use; D010488:Polyarteritis Nodosa / Q000188:drug therapy; D012595:Scleroderma, Systemic / Q000188:drug therapy; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D015122:Mercaptopurine; D001379:Azathioprine
Komplikationen der immunsuppressiven Therapie mit Zytostatika bei Autoaggressionskrankheiten unter besonderer Berücksichtigung der cholestatischen Hepatose.